Triage Strategies Based on C-Reactive Protein Levels and SARS-CoV-2 Tests among Individuals Referred with Suspected COVID-19: A Prospective Cohort Study
Authors:
- Erika Olivia BoyesenEBErika Olivia Boyesen
- Ida Maria BalsbyIBIda Maria Balsby
- Marius HenriksenMHMarius Henriksen
- Robin ChristensenRCRobin Christensen
- Jens Henning RasmussenJRJens Henning Rasmussen
- Finn Erland NielsenFNFinn Erland Nielsen
- Hanne NygaardHNHanne Nygaard
- Lennart Jan Friis-HansenLFLennart Jan Friis-Hansen
- Susanne Dam NielsenSNSusanne Dam Nielsen
- Rebekka Faber ThudiumRTRebekka Faber Thudium
- Celeste PorsbergCPCeleste Porsberg
- Lars Erik KristensenLKLars Erik Kristensen
Open Access
- 30 December 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (1) , 201
Abstract
C-reactive protein (CRP) has prognostic value in hospitalized patients with COVID-19; the importance of CRP in pre-hospitalized patients remains to be tested. Methods: Individuals with symptoms of COVID-19 had a SARS-CoV-2 PCR oropharyngeal swab test, and a measurement of CRP was performed at baseline, with an upper reference range of 10 mg/L. After 28 days, information about possible admissions, oxygen treatments, transfers to the ICU, or deaths was obtained from the patient files. Using logistic regression, the prognostic value of the CRP and SARS-CoV-2 test results was evaluated. Results: Among the 1006 patients included, the SARS-CoV-2 PCR test was positive in 59, and the CRP level was elevated (>10 mg/L) in 131. In total, 59 patients were hospitalized, only 3 of whom were SARS-CoV-2 positive, with elevated CRP (n = 2) and normal CRP (n = 1). The probability of being hospitalized with elevated CRP was 4.21 (95%CI 2.38–7.43, p < 0.0001), while the probability of being hospitalized with SARS-CoV-2 positivity alone was 0.85 (95%CI 0.26–2.81, p = 0.79). Conclusions: CRP is not a reliable predictor for the course of SARS-CoV-2 infection in pre-hospitalized patients. CRP, while not a SARS-CoV-2 positive test, had prognostic value in the total population of patients presenting with COVID-19-related symptoms.Keywords
Funding Information
- H. Lundbeck A/S (R349-2020-732)
- Oak (OCAY-18-774-OFIL)
This publication has 22 references indexed in Scilit:
- Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019Clinical Infectious Diseases, 2020
- Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemicAnnals of Medicine, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Role of C-Reactive Protein at Sites of Inflammation and InfectionFrontiers in Immunology, 2018
- C-Reactive Protein and Respiratory Viral InfectionKorean Journal of Clinical Laboratory Science, 2017
- IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in InfectionsPLOS Pathogens, 2016
- cobas 8000 Modular Analyzer Series Evaluated under Routine-like Conditions at 14 Sites in Australia, Europe, and the United StatesSLAS Technology, 2013
- Strategy for intention to treat analysis in randomised trials with missing outcome dataBMJ, 2011
- Human C-reactive protein: expression, structure, and functionMolecular Immunology, 2001
- Basic statistics for clinicians: 4. Correlation and regression.1995